This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Polio

  1. This fact sheet provides an overview of the novel oral polio vaccine (nOPV) program, a consortium of PATH and partners that are working to advance novel vaccine candidates that will enable complete eradication and minimize the risk of polio making a comeback.
    Published: February 2022
    Type: Resource Page
  2. PATH provides immunization support in the DRC, this is the first newsletter of 2021 detailing progress of our work.
    Published: October 2021
    Type: Resource Page
  3. Vaccination against polio will continue long after the last cases are recorded. We’re looking for ways to hasten eradication—and remain fortified against the disease for years to come.
    Published: September 2021
    Type: Article
  4. Fact sheet: Bag-Mediated Filtration System (BMFS)
    Published: July 2021
    Type: Resource Page
  5. Fact Sheet: Advancing polio eradication: A rapid diagnostic test for primary immunodeficiency diseases
    Published: July 2021
    Type: Resource Page
  6. Together with over 400 external stakeholders from across 50 countries, PATH has crafted a new institutional strategy that responds to the current crises we face as a global community, to the needs and priorities of our local partners, and to the resounding calls for the continued transformation of our sector. To bring our new strategy to life for our external partners, we’ve developed a strategy brochure. The brochure explains why PATH exists (our mission), what we will do (our priorities) and, perhaps most importantly, how we will do it (our change strategies).
    Published: June 2021
    Type: Resource Page
  7. How PATH’s product-to-impact expertise helped guide the novel oral polio vaccine to approval.
    Published: April 2021
    Type: Article
  8. The world is on the brink of eradicating polio. A new vaccine from PATH and partners could help us reach the finish line.
    Published: November 2020
    Type: Article
  9. Since 2017, the Democratic republic of Congo (DRC) has worked to halt an outbreak of vaccine-derived polio virus type 2 (cVDPV2) in several of its South-Eastern provinces. Low immunity of children in Haut-Lomami, Tanganyika, and Lualaba provinces is indicative of low routine immunization coverage and the risk of the spread of polio to other areas. These three provinces represent some of the lowest immunization coverage rates in the country and the importance of strengthening these health systems.PATH and partners are working to contribute to the interruption of cVDPV2 transmission in DRC by improving the quality of the outbreak response and ensuring sustainable routine immunization financing and immunization systems are strengthened through policy advocacy activities. This newsletter is produced quarterly to highlight program work related to these objectives.
    Published: July 2020
    Type: Resource Page
  10. PATH and partners created a simple device that could accelerate polio eradication and help researchers track SARS-CoV-2.
    Published: May 2020
    Type: Article
Load more